Use of a probiotic to decrease enteric hyperoxaluria.
Published in Kidney international • Sep 1, 2005
NobleIDNI8P19W24R20S48
Authors:,,
John C Lieske
David S Goldfarb
Claudio De Simone
Abstract
BACKGROUND: Patients with inflammatory bowel disease have a 10- to 100-fold increased risk of nephrolithiasis, with enteric hyperoxaluria being the major risk factor for these and other patients with fat malabsorptive states. Endogenous components of the intestinal microflora can potentially limit d...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!